Acute gall stone pancreatitis is a potentially lethal disease in the elderly. Established treatment consists of supportive medical therapy followed by planned cholecystectomy.' Removing the gall bladder effectively prevents further episodes of acute pancreatitis2 but in the elderly has considerable morbidity.3 If the gall bladder is left intact the risk of further pancreatitis is cumulative and at least 350/o.2 4 5 In the elderly patient with gall stone jaundice endoscopic sphincterotomy (ES) has been established as definitive treatment if gall bladder symptoms are absent,6 7 and has the advantage of lower morbidity than cholecystectomy in these patients. Recent was deemed undesirable because of advanced age or poor medical condition. Pancreatitis was diagnosed when a serum amylase concentration of over 1000 U/1 (normal range 70-300 U/l) was present in a patient with an appropriate clinical presentation. Gall stone pancreatitis was established when gall stones were shown in the gall bladder or bile ducts by ultrasound scan or ERC. In each centre ES was performed by a single endoscopist and data were collected since the technique was introduced to the hospital (October 1983 in Plymouth; February 1989 in Taunton) until the end of the study in November 1993. ES was deemed complete when the entire submucosal portion of the bile duct was divided and all duct stones cleared. Bile ducts were cleared of stones by balloon or basket trawl and in three patients mechanical lithotripsy was necessary. Three patients had temporary biliary drainage (one pig tail stents, two nasobiliary drainage) after initial ERC before duct clearance was achieved at a second ERC. One patient had the permanent insertion of pig tail stents after incomplete extraction of multiple large duct stones. All patients were followed up by outpatient or telephone contact. Further details of symptoms, hospital admissions, and cause of death after ES were obtained from hospital or general practitioner records.
Results
Fifty one patients (median age 78, range 54-92) were treated expectantly by two endoscopists without planned cholecystectomy (Figure) . Thirty eight (74.5%) were aged over 70. Two patients died within 30 days of ES, one (age 63) of bronchopneumonia and cirrhosis, the other (age 86) of bronchopneumonia. Two patients were admitted to a high dependency unit because of oversedation and recovered completely within 24 hours. There were no episodes of acute pancreatitis, no overt gastrointestinal haemorrhage, and no duodenal perforations after ERC.
Forty eight patients had a technically complete ES and required 57 ERCs to achieve duct clearance (mean 1. 19 patients with technically successful ES survived longer than one month, of whom 14 died from non-biliary causes a mean of 25.0 months after ES (range 2-94). None of these patients had further pancreatitis. The remaining 32 surviving patients had no further pancreatitis at a mean 29.4 months (range 2-121), a total of 108 patient years of pancreatitis free survival. There was no correlation between age at ES and pancreatitis free survival. Four of these patients had biliary colic or cholecystitis during follow up, of whom two underwent cholecystectomy after a mean 13.5 months.
In three patients ES was recorded in the endoscopic record as inadequate with incomplete incision of the submucosal bile duct. These failures resulted from an overhanging fold of mucosa obscuring the bile duct (n= 1), technical difficulty with a broken scope (n= 1), and patient intolerance of the procedure (n= 1). The first two of these patients developed a further attack of acute pancreatitis on follow up. Of these, the first patient's bile duct was cleared of stones during incomplete ES and residual stones were shown in the gall bladder; and the second had a single 2 mm stone left in the bile duct and was treated expectantly.
Discussion
In this series no further episode of acute pancreatitis occurred during 108 patient years of follow up after successful ES. It is known that ES can reduce the morbidity and mortality of severe acute gall stone pancreatitis. 7 These results suggest that ES may also prevent further acute pancreatitis if the bile duct is cleared but confirmed stones remain in the gall bladder, thus extending the findings of others.10 Recurrent pancreatitis was also prevented in the one patient who had permanent insertion of pig tail stents after incomplete duct clearance.
Stones were present in 74.50/o of bile ducts and were of median size 7 mm. This may overestimate the size of duct stones that cause pancreatitis. In 13 patients the ducts were clear of stones, in keeping with the suggestion that it is small stones that cause pancreatitis and then pass spontaneously.1 11 We presume that ES permits any further stones in the bile duct to pass into the duodenum without causing recurrent pancreatitis. The finding that recurrent pancreatitis occurred in one patient with a clear bile duct and remaining gall bladder stones, but with an incomplete ES, supports this.
Studies of ES without cholecystectomy in gall stone jaundice suggest that less than 1 0% of patients will develop gall bladder symptoms requiring cholecystectomy within two years.6 This study suggests the risk after acute gall stone pancreatitis may be similar with only 4% requiring cholecystectomy after a mean follow up of nearly 2-5 years. As gall stone pancreatitis increasingly affects patients over 7012 these results suggest that in these patients ES might substitute for cholecystectomy. If a policy of ES without cholecystectomy were to be adopted in the elderly and unfit the risk of recurrent attacks of pancreatitis would be minimised and many patients would be spared the discomfort and potential complications of cholecystectomy. 
